FCG: Biopsy Needle

Product code FCG, “Biopsy Needle” in FDA's classification database, is a Class II device type under 21 CFR 876.1075 (gastroenterology-urology biopsy instrument), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 133 clearances under FCG, 34 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
FCG
Regulation
21 CFR 876.1075
Class
II
Panel
Gastroenterology, Urology
Clearances
133
Most recent
Oct 24, 2025
Median review, last 2 years
103 days
Third-party review
Eligible
Implant
No

What it covers

A gastroenterology-urology biopsy instrument is a device used to remove, by cutting or aspiration, a specimen of tissue for microscopic examination. This generic type of device includes the biopsy punch, gastrointestinal mechanical biopsy instrument, suction biopsy instrument, gastro-urology biopsy needle and needle set, and nonelectric biopsy forceps. This section does not apply to biopsy instruments that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.

The identification in 21 CFR 876.1075, gastroenterology-urology biopsy instrument. FDA gives FCG no definition of its own, so the regulation’s describes it.

Recent clearances

510(k)DeviceApplicantDecisionType
K252646Single-Use Fine Needle Biopsy (FNB) device (NA-U210H)Olympus Medical Systems Corp.Oct 24, 2025Traditional
K250994ClearTip FNA and FNB TypesFinemedix Co., Ltd.Aug 21, 2025Traditional
K241209EchoTip AcuCore™ EUS Biopsy Needle (ECHO-BX-19)Cook Ireland, Ltd.Jul 29, 2024Traditional
K231422Precision GILimaca Medical, Ltd.Aug 28, 2023Traditional
K231267ClearTipFinemedix Co., Ltd.Jun 30, 2023Traditional
K230909EchoTip® AcuCore™ Ultrasound Biopsy Needle (ECHO-BX-3-22)Cook Ireland, Ltd.May 30, 2023Traditional
K212423EndoDrill® Model XBibbinstruments ABMar 29, 2023Traditional
K212819Disposable Biopsy Refill NeedleSuzhou Leapmed Healthcare CorporationJul 6, 2022Traditional
K212822Disposable Coaxial Biopsy NeedleSuzhou Leapmed Healthcare CorporationJul 6, 2022Traditional
K210476EchoTip Ultra Endoscopic Ultrasound Needle, EchoTip ProCore HD Ultrasound Biopsy Needle, EchoTip Ultra Endobronchial High Definition Ultrasound Needle, EchoTip ProCore Endobronchial High Definition Ultrasound Biopsy NeedleCook Ireland, Ltd.May 20, 2021Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 133 with a free account)

Clearances by year

34 FCG 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
20252103
2024190
2023482
20222306
2021190
20201240
20186140
20173166
2016363
2015491
2014588
2013156
20111222

Who submits

20 applicants cleared a FCG device since 2011. 38% of the clearances went to applicants in United States, then Japan (18%), Ireland (15%) and China (12%). By type: Traditional 97% and Special 3%. 1 went through a third-party review organization.

ApplicantClearances since 2011
Olympus Medical Systems Corp.6
Cook Ireland, Ltd.5
Finemedix Co., Ltd.3
Covidien, LLC( Formerly Beacon Endoscopic Corp.)2
Suzhou Leapmed Healthcare Corporation2
Wilson-Cook Medical, Inc.2
Apriomed AB1
Beacon Endoscopic1

How FDA classifies it

(1) Class II (performance standards).

(2) Class I for the biopsy forceps cover and the non-electric biopsy forceps. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.

From 21 CFR 876.1075. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 876.1075 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent FCG clearances declared.

Ask about FCG

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about FCG

What is FDA product code FCG?

Product code FCG, “Biopsy Needle” in FDA's classification database, is a Class II device type under 21 CFR 876.1075 (gastroenterology-urology biopsy instrument), reviewed by FDA's Gastroenterology, Urology panel. FDA's 510(k) database lists 133 clearances under FCG, 34 of them since 2011.

How many 510(k) clearances are there under FCG?

FDA’s 510(k) database listed 133 clearances under FCG as of Oct 29, 2026, 34 of them decided since 2011; the most recent decision was Oct 24, 2025. The Predicate Finder searches the live database.

How long does FDA take to clear a FCG 510(k)?

For the 2 FCG clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 103 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most FCG clearances?

Since 2011: Olympus Medical Systems Corp. (6), Cook Ireland, Ltd. (5), Finemedix Co., Ltd. (3), Covidien, LLC( Formerly Beacon Endoscopic Corp.) (2) and Suzhou Leapmed Healthcare Corporation (2). 20 applicants have cleared a FCG device in that time.

Sources

  1. FDA product classification: FCG · Product Classification database
  2. 21 CFR 876.1075: Gastroenterology-urology biopsy instrument · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for FCG · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow FCGGet an email when FDA clears, recalls or publishes guidance for FCG devices.

Know what FDA already cleared.